| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2020 | ORGO Organogenesis Holdings Inc. | MacKie Wayne D | Director | Buy | 42,726 | $3.25 | $138,859.50 | +36.0% | |
| Nov 17, 2020 | ORGO Organogenesis Holdings Inc. | Leibowitz Arthur S | Director | Buy | 6,943 | $3.25 | $22,564.75 | +29.5% | |
| Nov 17, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 26,000 | $0.26 | $6,685.00 | - | |
| Nov 16, 2020 | PCRX Pacira Biosciences, Inc. | Brege Laura62 | Director | Sell | 12,000 | $65.95 | $791,400.00 | -60.2% | |
| Nov 13, 2020 | PCRX Pacira Biosciences, Inc. | Reinhardt Max79 | President | Sell | 25,000 | $63.38 | $1,584,390.00 | -33.8% | |
| Nov 13, 2020 | ZTS Zoetis Inc. | Alaix Juan Ramon | Director | Sell | 91,747 | $165.46 | $15,180,561.23 | -74.8% | |
| Nov 13, 2020 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 3,000 | $63.81 | $191,430.00 | -18.5% | |
| Nov 13, 2020 | PCRX Pacira Biosciences, Inc. | Winston Roy68 | Chief Clinical Officer | Sell | 5,000 | $62.00 | $310,000.00 | -12.6% | |
| Nov 13, 2020 | CGC Canopy Growth Corp | Kovacevic Rade Nikola | President | Sell | 241,038 | $31.55 | $7,604,360.46 | -39.1% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,257 | $90.72 | $204,754.59 | -7.0% | |
| Nov 12, 2020 | CGC Canopy Growth Corp | Shaer Phillip Stephen | Chief Legal Officer | Sell | 70,000 | $31.03 | $2,172,100.00 | -85.4% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 2,257 | $90.73 | $204,777.61 | -16.3% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 2,257 | $90.73 | $204,775.80 | -7.2% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 2,257 | $90.74 | $204,806.50 | -1.5% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Gano Kyle54 | Chief Business Development Off | Sell | 2,257 | $90.73 | $204,770.39 | -2.3% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 2,257 | $90.74 | $204,810.11 | -18.4% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 2,257 | $90.71 | $204,722.99 | -11.5% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 2,257 | $90.74 | $204,809.89 | -14.3% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 2,257 | $90.73 | $204,783.70 | -2.7% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 3,390 | $90.78 | $307,747.59 | -0.8% | |
| Nov 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | MacDonald Kelly | Chief Accounting Officer | Sell | 3,561 | $11.75 | $41,841.75 | -3.7% | |
| Nov 11, 2020 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Sell | 9,300 | $7.30 | $67,890.00 | -0.2% | |
| Nov 11, 2020 | AMRN Amarin Corp Plc\uk | Thero John F | President And CEO | Sell | 567,405 | $4.08 | $2,317,157.64 | -8.8% | |
| Nov 10, 2020 | ANIK Anika Therapeutics, Inc. | Land Raymond J | Director | Sell | 3,446 | $36.77 | $126,709.42 | -25.7% | |
| Nov 10, 2020 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 39,391 | $91.79 | $3,615,680.11 | -1.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.